Site US01007 — Los Angeles, California

Site US01007 is a clinical research site located in Los Angeles, California, United States 90033.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Site US01007 has participated in 1 clinical trials.

Therapeutic areas: Metastatic Renal Cell Carcinoma.

Sponsors: Astellas Pharma Global Development, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site US01007?

Site US01007 has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site US01007 conducted?

Site US01007 has 1 clinical trials on record. Their work covers Metastatic Renal Cell Carcinoma.

Is Site US01007 accredited by Crixeo Health?

Site US01007 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site US01007?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.